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Pathological fibrosis is characterized by the excessive accumulation of extracellular matrix 72 (ECM) proteins, most notably fibrillar collagens. The majority of ECM in organ fibrosis is 73 deposited by myofibroblasts, proliferative and motile cells characterized by the expression of α-74 smooth muscle actin (α-SMA), which either migrate to the site of injury or differentiate from 75 preexisting cells in the organ. In the liver, the major myofibroblast precursor cells are hepatic 76 stellate cells and portal fibroblasts. 77
Myofibroblast differentiation from precursor cells requires mechanical tension. This has been 78
shown in vitro for general fibroblast to myofibroblast activation (14) as well as for both hepatic 79 stellate cell and portal fibroblast activation to myofibroblasts in the liver (19, 36) and suggests 80 that increases in liver stiffness precede myofibroblast activation. We have used ex vivo livers to 81
show that this is true in a rat carbon tetrachloride (CCl 4 ) model of liver fibrosis and that the 82 mechanical heterogeneity of the liver also increases early after injury in this model (12, 17) . 83
Increases in liver stiffness are multifactorial and may include increased interstitial pressure from 84 edema, increased ECM protein expression, and collagen stiffening due to cross-linking.
85
Potentially relevant collagen cross-linking agents include tissue transglutaminases, which are 86 increased in residual septae after fibrosis resolution (but have recently been shown to have 87 minimal impact on the progression of fibrosis in rodent models (27)), and lysyl oxidase (LOX) 88 family enzymes. The LOXs are secreted copper-dependent amine oxidases that initiate the 89 process of covalent intra-and intermolecular cross-linking of collagens and elastin (34, 35).
90
There are five isoforms: LOX itself, and the LOX-like enzymes LOXL1, LOXL2, LOXL3, and 91 LOXL4, all encoded by separate genes and with overlapping but distinct functions and substrate 92 specificity. Multiple studies have shown that LOX-mediated cross-linking significantly increases 93 ECM stiffness (8, 15, 20, 29) . 94
The LOXs play an important role in liver fibrosis. LOX expression in the liver, as determined by 95 immunohistochemistry, is upregulated as early as 24 hours after bile duct ligation (BDL) and 96 continues to increase through at least 72 hours, preceding increases in α-SMA (7). In a chronic 97
CCl 4 model of fibrosis, LOX activity increased 30 fold in rat liver and 15 fold in plasma after five 98 weeks (32). Treatment of rats with β-aminoproprionitrile (BAPN), an inhibitor of LOX family 99 cross-linking enzymes, reduced early increases in liver stiffness in the CCl 4 model (12); we and 100 others have shown that inhibition of LOX family activity also results in decreased numbers of 101 myofibroblasts and decreased fibrosis (9, 10, 12). A recent study showed that treatment with a 102 LOXL2 blocking antibody blunted liver fibrosis in CCl 4 -treated rats (2). 103
The LOXs cross-link newly synthesized collagen and elastin fibrils (34, 35 
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197
Liver mechanics change early after injury. We previously used the rat CCl 4 model of liver 198 fibrosis to demonstrate that liver stiffness increased early after injury, before the first major wave 199 of myofibroblast differentiation (12). Treating animals with the LOX inhibitor BAPN suggested 200 that LOX family activity was responsible at least in part for this increase (12). We have now 201 carried out more detailed mechanical measurements and show that they are consistent with 202 increased collagen cross-linking as a cause of increased stiffness. We determined the stiffness 203 (G') of livers from 0 to 14 days after the initiation of CCl 4 intoxication. In all cases, livers were 204 removed 3-4 days after an injection of CCl 4 , when edema was minimal. As we observed 205 previously (12), the livers of CCl 4 -treated animals were significantly stiffer than normal livers 206 beginning as early as 7 days after the start of treatment (Fig. 1A ). When we increased shear 207 strain, there was marked strain softening in samples from all time points (Fig. 1A) , although the 208 degree of softening was less pronounced at later time points (Fig. 1B) . The reduction in strain 209 softening paralleled a decrease in the ratio of the loss modulus to the storage modulus (G"/G'; 210 Fig. 1C ) with strain, consistent with formation of a more elastic tissue due to increased collagen 211 cross-linking. 212
To rule out edema as a cause of the increased stiffness, we examined livers at 1 and 2 days 213 after CCl 4 injection, when there is significant edema. G' at minimal strain was increased, but 214 there was still pronounced strain softening ( Fig. 2A) , and the shape of the G"/G' vs. strain curve 215 was similar to that of normal, as opposed to early fibrotic liver (day 14; Fig. 2B ). Thus, the strain-216 dependence of the shear modulus and G"/G' enabled us to differentiate edematous from fibrotic 217 liver and suggested that matrix cross-linking, rather than edema, was the cause of the 218 significant mechanical changes we observed. 219
Increased collagen cross-linking is seen early after injury and correlates with stiffness. To 220 investigate whether altered mechanics are associated with collagen cross-linking, we measured 221 the LOX-mediated collagen cross-links pyridinoline and deoxypyridinoline directly in livers from 222 rats treated with CCl 4 for up to 70 days. These trivalent, mature, non-reducible cross-links are 223 formed involving two hydroxylysine aldehyde (Hyl ald ) residues in the telopeptides and one Hyl (in 224 the case of pyridinoline) or lysine (deoxypyridinoline) residue in the helical domain of collagen 225 (39). We found that the content of pyridinoline increased significantly at late time points (70 226 days; Fig. 3A ), while the content of deoxypyridinoline was significantly elevated by 10 days and 227 continued to increase with time (Fig. 3B ). There was no significant correlation between 228 pyridinoline and whole liver stiffness (Fig. 3C) ; however, deoxypyridinoline cross-links were 229 significantly correlated with liver stiffness (r 2 = 0.47, p=0.0001; Fig. 3D Kupffer cells, and SEC. We lysed cells immediately after isolation, without intervening, thus 245 avoiding culture artifacts. We found that hepatic stellate cells and portal fibroblasts are the major 246 sources of LOXL1, 2, and 3 ( Fig. 5B-D , compare white bars). LOXL4 is widely expressed, and 247 LOX in the normal liver is expressed primarily by hepatocytes and portal fibroblasts (Fig. 5A, E) .
248
Cholangiocytes demonstrated minimal expression of any of the LOX family members when 249 compared with normal portal fibroblasts (data not shown). 250
To determine whether increases in LOX family expression precede whole liver mechanical 251 changes, we examined primary cells isolated at early time points after liver injury induced by 252 BDL (1 day) or CCl 4 intoxication (2 days) (Fig. 5) . We observed again that expression was 253 limited to hepatic stellate cells and portal fibroblasts, except for LOXL4 which was expressed by 254 all cells studied except Kupffer cells (Fig. 5E) . The only significant increase in expression at 255 these time points was in LOX expression by hepatic stellate cells after CCl 4 (Fig. 5A) . 256
LOX is the major isoform upregulated in early CCl 4 -mediated fibrosis. Further evaluation of LOX 257
family expression in hepatic stellate cells and portal fibroblasts freshly isolated from livers 7 258 days after initiation of CCl 4 treatment (2 injections) showed that LOX continues to be the major 259 isoform increased at this time point, and that its mRNA is increased in both cell types (Fig. 6A) .
260
Other isoforms, with the exception of LOXL1, which increased slightly in portal fibroblasts 261 (p=0.125), showed decreased mRNA expression (Fig. 6B-E produce measurable amounts of mRNA for collagens I, III, and IV in the normal liver (Fig. 8) .
276
Although there is a small amount of collagen IV mRNA expression by hepatocytes, SEC, and 277
Kupffer cells, there is no production of the fibrillar collagens I and III by any cells other than 278 hepatic stellate cells and portal fibroblasts. 279
We examined expression of these ECM proteins early after injury in representative models of 280 biliary and parenchymal fibrosis. With the exception of an increase in the α2 chain of collagen I 281 by portal fibroblasts after BDL, collagen mRNA expression remains stable early after injury 282 induced by CCl 4 treatment (2 days) or BDL (1 day) (Fig. 8A, B, C) . Elastin, which has been used 283 as a marker of portal fibroblasts in vitro (19), is expressed primarily by portal fibroblasts in the 284 normal liver but also to a small extent by hepatic stellate cells in the injured liver, and its 285 expression by portal fibroblasts is significantly increased after BDL (Fig. 8D) . Thus, the cells 286 responsible for pathological ECM deposition in fibrosis also express collagens in the normal 287 liver and in the injured but non-fibrotic liver. Interestingly, there is mRNA expression of the 288 myofibroblast marker α-SMA in hepatic stellate cells and portal fibroblasts at baseline, 289
suggesting that there is a small population of myofibroblasts (or primed myofibroblast 290 precursors) in the normal liver (Fig. 9) . 291
Discussion 292
We demonstrate here that 1) normal livers undergo pronounced strain softening, and that this 293 as well as the G"/G' ratio (reflecting the relationship between viscosity and elasticity in a 294 sample) change markedly within days of liver injury; 2) LOX family-mediated pyridinoline and 295 deoxypyridinoline collagen cross-links increase with injury, and deoxypyridinoline collagen 296 cross-links, which rise at early time points, are significantly correlated with liver stiffness; 3) LOX 297
and to a lesser extent LOXL1 are the major LOX family members with increased expression in 298 early injury; and 4) hepatic stellate cells and portal fibroblasts are the major cellular sources of 299 fibrillar collagens and LOXs in the normal liver and early after injury. These findings have 300 important implications: 1) that mechanical changes are due to collagen cross-linking and may 301 mediate major changes in the behavior of cells of the liver at early time points after injury; 2) 302 hepatic stellate cells and portal fibroblasts, which become the major collagen-secreting cells in 303 the fibrotic liver, are "primed" for this function through their matrix-secreting roles in the normal 304 liver; and 3) hepatic stellate cells and portal fibroblasts, by virtue of their early expression of 305 LOXs, may have an important role in early injury distinct from their role as matrix producing 306 cells. 307
Our findings that liver stiffness increases early after injury in both the CCl 4 and BDL models 308
( (12) and Fig. 4) , and that hepatic stellate cells and portal fibroblasts require increased 309 mechanical tension in order to differentiate to myofibroblasts (19, 25) suggest a model whereby 310 increased stiffness shortly after injury drives the myofibroblastic and then the fibrotic response.
311
Potential causes of increased liver stiffness include changes in the matrix (cross-linking or 312 increased matrix deposition) and tension due to edema or vascular pressure. We demonstrate 313
here that edema can be differentiated from other causes of increased liver stiffness, and that 314 the altered mechanics of the liver at day 7 and later are not consistent with edema. The 315 reduction in strain softening as well as flattening of the G"/G' vs. strain curves after injury are 316 most consistent with increased matrix cross-linking. Notably, most studies of stiffness and cell 317 phenotype, including our previous work with stellate cells and portal fibroblasts, has focused on 318 G' (or the closely related Young's modulus E). The implications of strain softening and the G"/G' 319 ratio on cell behavior are not well understood, but may add another layer of complexity to the 320 role of mechanics in disease pathophysiology. 321
We previously demonstrated that inhibition of LOX-family enzymatic activity resulted in blunting 322 of the liver stiffness response early after injury and in decreased numbers of myofibroblasts 323 (12); others have also reported decreased fibrosis in animal models after treatment with LOX 324 family inhibitors (2, 9, 10). Critical to our model is that cross-linking occurs before the 325 development of significant fibrosis. We therefore examined LOX family and collagen expression 326 within a small window of time. Our data suggest that small perturbations in expression of LOX 327 itself (which likely occur in response to increased TGF-β) occur at early time points after injury.
328
Surprisingly given the success of an anti-LOXL2 antibody in preventing CCl 4 -induced fibrosis in 329 rodents, we did not observe significant changes in LOXL2 at the time points we studied (2); 330 however, it may increase at later time points after injury and play an important role in fibrosis 331 progression rather than initiation. While early fibrosis represents the process of injury repair and 332 is protective (3), later fibrosis could be considered a pathologic process and may involve 333 different subsets of ECM proteins (which undoubtedly contribute to increased stiffness) and 334 ECM modifying enzymes. 335
Our data show that at early points after the initiation of CCl 4 intoxication, pyridinoline and 336 deoxypyridinoline cross-links begin to increase. This is consistent with findings from cirrhotic 337 human livers, when both types of cross-link are increased (4). These are trivalent, stable cross-338 links derived from the immature divalent cross-links (39). In the current study, due to the limited 339 amounts of material available, we were unable to measure the precursor aldehydes or immature 340 cross-links that would likely have been increased at earlier time points. Liver stiffness is 341 increased by day 7 (Fig. 1A) , while deoxypyridinoline does not increase until 10 days (Fig. 3B) , 342
an incongruity likely secondary to immature cross-links that we were unable to measure. We 343 found a significant correlation between deoxypyridinoline but not pyridinoline cross-links and 344 liver stiffness (G') in the subset of livers for which we had stiffness data. decreases in LOX family mRNA expression after injury (Fig. 5) . 360
It would be advantageous for the liver to have the ability to mount a rapid response after injury.
361
Recently published work showed that hepatic stellate cells in the normal liver are 362 heterogeneous and that a subpopulation of these cells express myofibroblast markers, 363 apparently primed to initiate repair processes in the context of liver injury (6). We observed α-364 SMA expression in both hepatic stellate cells and portal fibroblasts in the normal liver (Fig. 9) . It 365 is tempting to speculate that portal fibroblast and hepatic stellate cell subsets expressing α-366 SMA serve as "rapid responders" and that they are also responsible for the LOX and collagen 367 mRNA expression we observed in the non-injured liver, although this requires further evaluation 368 since our studies did not involve single cell analyses. All of the LOXs are upregulated in 369 response to TGF-β ((31); and data not shown), which is one of the earliest growth factors to 370 increase after injury; TGF-β-mediated increases in LOX production in early injury, combined 371 with ongoing deposition of small amounts of collagen, could result in modest regional changes 372 in stiffness, which we have observed in rodent livers as early as day 6 after initiation of CCl 4 373 treatment (16). Recent reports suggest that small increases in collagen stiffness can be 374 amplified by cells, suggesting that they could be significant in driving the progression of fibrosis 375 (38). 376
Although the cellular source of collagen in fibrosis was at one time the source of significant 377 debate, definitive studies demonstrated that hepatic stellate cells (as opposed to hepatocytes) 378
were the major fibrogenic population (22) (23) (24) . (These studies were carried out before portal 379 fibroblasts were routinely isolated.) Maher et al. used RNase protection assays to evaluate 380 mRNA expression in isolated cells, and found that, at 5 days after BDL or 14 days after initiation 381 of CCl 4 treatment, hepatic stellate cells were the major source of types I and III collagen while 382
SECs were a minor source (22 both C and D is in reference to samples taken at 6 hours after surgery. n=5-6 for all data 563 points.*, p<0.05; ***, p<0.005. 564 sinusoidal endothelial cells (SEC) were isolated from the livers of healthy rats and rats 2 days 567 after a CCl 4 injection or 1 day after BDL. Cells were lysed for mRNA isolation immediately, and 568 real-time PCR was carried out to determine expression of all 5 LOX family members (LOX (A), 569 LOXL1 (B), LOXL2 (C), LOXL3 (D), LOXL4 (E)). All are expressed; however, hepatic stellate 570 cells and, to a lesser extent, portal fibroblasts, are the major producers of LOXs in the normal 571 liver and shortly after injury. *, p<0.05; **, p<0.01; ***, p<0.005. 572 Fig. 6 . LOX but not other family member mRNA expression is upregulated in hepatic stellate 573 cells and portal fibroblasts after injury. Cells were isolated from rat livers 7 days after beginning 574 treatment with CCl 4 (after a total of 2 injections, day 1 and day 4) and were analyzed by real-575 time PCR for LOX family expression. Only LOX is significantly increased at this time point. *, 576 p<0.05. 577 days. Conditioned media (CCM) were examined by a LOX family activity assay at days 1 and 7 580 after isolation. *, p<0.05. 581 
